Derek Chalmers Net Worth & Insider Trades

Derek Chalmers - President & CEO, Cara Therapeutics, Inc

As of September 9, 2021

What is Derek Chalmers's Net Worth?

The current estimated net worth of Cara Therapeutics, Inc's President & CEO, Derek Chalmers, is estimated to be about $10.02M . Derek Chalmers owns about 991,405 units of Cara Therapeutics, Inc common stock. In the last 7 years at Cara Therapeutics, Inc, Derek Chalmers has sold an estimated value of $7.2M worth.

What is Derek Chalmers's Past Insider Trading?

Derek Chalmers's largest purchase order was 20,000 units , worth over $49.6K on November 3, 2017. Derek Chalmers's largest sale order was 20,000 units , worth over $475.8K on October 3, 2018. In total, Derek Chalmers has made about 48 transactions over 7 years of their time at Cara Therapeutics, Inc. Derek Chalmers usually trades in December, with the busiest year in 2020. The most recent transaction was a sale order of 20,000 units , worth over $309.4K on September 9, 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DEREK CHALMERS

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Derek Chalmers's' Mailing Address?

  • Mailing address is C/o Cara Therapeutics, Inc. 1 Parrott Drive Shelton CT 06484 CT

What are Cara Therapeutics, Inc's Past Insider Trades?

Cara Therapeutics, Inc's most recent insider trade came on August 4, 2023 by Christopher Posner who sold 4,307 units worth $13.22K . In the last 9 years, insiders at Cara Therapeutics, Inc have sold an estimated value of $27.36M and bought an estimated value of $21.23M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Joana Goncalves, Chief Medical Officer .

Cara Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...